mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.4 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.4 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.4 |